Fall 2026 Co-Op - Undergraduate Cell-Based Assay Development at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Undergraduate student in biology, biochemistry, pharmacology, or related field
Interest in cell biology, assay development, or drug discovery
Strong attention to detail and willingness to learn new techniques
Ability to work independently and collaboratively in a lab setting
Authorized to work in the US both at the time of hire and for the duration of employment (no immigration or visa sponsorship available)

Responsibilities

Learn principles of assay development and high-throughput screening
Develop skills in experimental design, data analysis, and scientific communication
Assist in developing and optimizing live-cell assays to monitor protein modifications
Evaluate assay performance metrics such as signal-to-background ratio and reproducibility
Support compound screening efforts and help interpret biological responses
Contribute to assay documentation, data visualization, and protocol refinement
Collaborate with cross-functional teams to explore workflow improvements
Gain experience with live-cell technologies and luminescence/fluorescence-based readouts

Skills

Cell-Based Assays

Assay Development

High-Throughput Screening

Live-Cell Screening

Luminescence Technologies

Multiplexed Assays

Data Analysis

Experimental Design

Scientific Communication

Compound Screening

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free